Latest News in the pharma Industry

Research & Development

NIH researchers find potential genetic cause of Cushing syndrome

NIH researchers find potential genetic cause of Cushing syndrome

1 Jun 2017

Finding may lead to therapies that prevent pituitary tumor recurrence.

Read more 
Hookipa Biotech announces data showing TheraT turns cold tumours hot

Hookipa Biotech announces data showing TheraT turns cold tumours hot

30 May 2017

TheraT mediated alarmin release crucial for active immunization in cancer immunotherapy.

Read more 
FDA accepts for priority review BMS’s application for Opdivo in previously treated hepatocellular carcinoma

FDA accepts for priority review BMS’s application for Opdivo in previously treated hepatocellular carcinoma

26 May 2017

Application is based on results from the Phase I/II CheckMate -040 trial.

Read more 
Inovio HIV vaccine elicits nearly 100% immune response rates in a clinical study

Inovio HIV vaccine elicits nearly 100% immune response rates in a clinical study

26 May 2017

Amongst highest levels of immune responses ever demonstrated in an HIV vaccine human study.

Read more 
Hovione starts clinical trial of its proprietary minocycline sterile ointment to treat a subset of anterior ocular inflammation

Hovione starts clinical trial of its proprietary minocycline sterile ointment to treat a subset of anterior ocular inflammation

25 May 2017

First clinical study using a patent protected minocycline API and formulation developed by Hovione.

Read more 
IPF patients treated with Ofev vs placebo twice as likely to have improved or stable lung function

IPF patients treated with Ofev vs placebo twice as likely to have improved or stable lung function

25 May 2017

Separate subgroup analysis demonstrates long-term efficacy of Ofev in slowing disease progression is maintained for up to 96 weeks in IPF patients who require dose adjustments to manage adverse events.

Read more 
New analyses reinforce the potential of Ultibro Breezhaler for COPD patients historically treated with steroids

New analyses reinforce the potential of Ultibro Breezhaler for COPD patients historically treated with steroids

23 May 2017

New analyses from the FLAME study suggest dual bronchodilator Ultibro Breezhaler provides similar or better efficacy versus steroid-containing therapies, regardless of blood eosinophil counts.

Read more 
Spiriva Respimat inhalation spray improves breathing for people with asthma regardless of BMI or allergic status

Spiriva Respimat inhalation spray improves breathing for people with asthma regardless of BMI or allergic status

23 May 2017

In all analyses, people experiencing uncontrolled asthma symptoms saw improvements in their breathing by adding Spiriva Respimat to an ICS or combination ICS/LABA.

Read more 
FDA approves Genentech’s Actemra for giant cell arteritis

FDA approves Genentech’s Actemra for giant cell arteritis

22 May 2017

Sixth FDA approval for Actemra since its US launch in 2010,

Read more 
Catalent and Therachon to advance clinical development of innovative protein therapy for achondroplasia

Catalent and Therachon to advance clinical development of innovative protein therapy for achondroplasia

15 May 2017

Catalent Biologics will use its proprietary GPEx technology to produce different protein variants for Therachon,

Read more 
Positive results for Lilly's three Phase III studies of galcanezumab for the prevention of migraine

Positive results for Lilly's three Phase III studies of galcanezumab for the prevention of migraine

14 May 2017

Read more 
Genentech to present new data on personalized medicines and cancer immunotherapies

Genentech to present new data on personalized medicines and cancer immunotherapies

12 May 2017

New pivotal results for Perjeta and Alecensa demonstrating improvement over standards of care.

Read more